107 related articles for article (PubMed ID: 30158361)
41. Is leptin a significant predictor of bone mineral density in postmenopausal Turkish women?
Oguz S; Tapisiz OL; Aytan H; Gunyeli I; Erdem S; Tuncay G; Bilge U; Mollamahmutoglu L
Rheumatol Int; 2009 Feb; 29(4):393-6. PubMed ID: 18818925
[TBL] [Abstract][Full Text] [Related]
42. Increased inflammatory potential of diet is associated with bone mineral density among postmenopausal women in Iran.
Shivappa N; Hébert JR; Karamati M; Shariati-Bafghi SE; Rashidkhani B
Eur J Nutr; 2016 Mar; 55(2):561-568. PubMed ID: 25778389
[TBL] [Abstract][Full Text] [Related]
43. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
[TBL] [Abstract][Full Text] [Related]
44. Spinal bone mass after long-term treatment with L-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis.
Hawkins F; Rigopoulou D; Papapietro K; Lopez MB
Calcif Tissue Int; 1994 Jan; 54(1):16-9. PubMed ID: 8118747
[TBL] [Abstract][Full Text] [Related]
45. Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma.
Görres G; Kaim A; Otte A; Götze M; Müller-Brand J
Eur J Nucl Med; 1996 Jun; 23(6):690-2. PubMed ID: 8662104
[TBL] [Abstract][Full Text] [Related]
46. Sources of variability in bone mineral density measurements: implications for study design and analysis of bone loss.
Nguyen TV; Sambrook PN; Eisman JA
J Bone Miner Res; 1997 Jan; 12(1):124-35. PubMed ID: 9240735
[TBL] [Abstract][Full Text] [Related]
47. Effect of Epidural Steroid Injection on Bone Mineral Density in Postmenopausal Women According to Antiosteoporotic Medication Use.
Kim YU; Karm MH; Cheong Y; Lee J; Kong YG; Kim SH; Suh JH
Pain Physician; 2016 Jul; 19(6):389-96. PubMed ID: 27454269
[TBL] [Abstract][Full Text] [Related]
48. The effects of short-term hormone replacement therapy on long-term bone mineral density.
Middleton ET; Steel SA
Climacteric; 2007 Jun; 10(3):257-63. PubMed ID: 17487653
[TBL] [Abstract][Full Text] [Related]
49. [Bone mineral density in patients with scleroderma systematica].
Alekperov RТ; Smirnov AV; Toroptsova NV; Kudinsky DM
Ter Arkh; 2016; 88(5):37-42. PubMed ID: 27239925
[TBL] [Abstract][Full Text] [Related]
50. Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study.
Schneider R; Schneider M; Reiners C; Schneider P
J Clin Endocrinol Metab; 2012 Nov; 97(11):3926-34. PubMed ID: 22977269
[TBL] [Abstract][Full Text] [Related]
51. Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.
Lydeking-Olsen E; Beck-Jensen JE; Setchell KD; Holm-Jensen T
Eur J Nutr; 2004 Aug; 43(4):246-57. PubMed ID: 15309425
[TBL] [Abstract][Full Text] [Related]
52. The effect of life-long thyroxine treatment and physical activity on bone mineral density in young adult women with congenital hypothyroidism.
Kempers MJ; Vulsma T; Wiedijk BM; de Vijlder JJ; van Eck-Smit BL; Verberne HJ
J Pediatr Endocrinol Metab; 2006 Dec; 19(12):1405-12. PubMed ID: 17252693
[TBL] [Abstract][Full Text] [Related]
53. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
54. Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.
Tiitinen A; Nikander E; Hietanen P; Metsä-Heikkilä M; Ylikorkala O
Maturitas; 2004 Jul; 48(3):321-7. PubMed ID: 15207898
[TBL] [Abstract][Full Text] [Related]
55. Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T
Rheumatol Int; 2018 May; 38(5):777-784. PubMed ID: 29294175
[TBL] [Abstract][Full Text] [Related]
56. Dietary potassium intake is beneficial to bone health in a low calcium intake population: the Korean National Health and Nutrition Examination Survey (KNHANES) (2008-2011).
Kong SH; Kim JH; Hong AR; Lee JH; Kim SW; Shin CS
Osteoporos Int; 2017 May; 28(5):1577-1585. PubMed ID: 28093633
[TBL] [Abstract][Full Text] [Related]
57. The Impact of Low-Dose Disease-modifying Anti-rheumatics Drugs (DMARDs) on Bone Mineral Density of Premenopausal Women in Early Rheumatoid Arthritis.
Rexhepi S; Rexhepi M; Sahatçiu-Meka V; Mahmutaj V; Boshnjaku S
Med Arch; 2016 Apr; 70(2):101-3. PubMed ID: 27147781
[TBL] [Abstract][Full Text] [Related]
58. Tibolone and osteoporosis.
Lazovic G; Radivojevic U; Milosevic V; Lazovic A; Jeremic K; Glisic A
Arch Gynecol Obstet; 2007 Dec; 276(6):577-81. PubMed ID: 17605023
[TBL] [Abstract][Full Text] [Related]
59. Differential effects of hormone replacement therapy on bone mineral density and axial transmission ultrasound measurements in cortical bone.
Knapp KM; Blake GM; Spector TD; Fogelman I
Osteoporos Int; 2003 Jun; 14(4):289-94. PubMed ID: 12730793
[TBL] [Abstract][Full Text] [Related]
60. [The bone mineral density and the markers of the osseous circle in children with non-toxic parenchymatous or nodular goiter long-time treated with L-thyroxine].
Zak T; Golenko A; B Wasikowa R; Jedrzejuk D; Noczyńska A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(1):13-7. PubMed ID: 15850533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
